Endothelin-receptor antagonists in therapy of pulmonary arterial hypertension

被引：0
|
作者：
Ghofrani, H. A. [1 ]
机构：
[1] Univ Giessen, Med Klin & Poliklin 2, Zentrum Innere Med, D-35385 Giessen, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2009年 / 134卷
关键词：
pulmonary arterial hypertension; endothelin-receptor antagonist; CHRONIC HEART-FAILURE; BOSENTAN;
D O I：
10.1055/s-0029-1225320
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S177 / S178
页数：2
相关论文
共 50 条
  • [21] Sitaxsentan - A new endothelin-receptor antagonist for the treatment of pulmonary arterial hypertension
    Reinhart, Kurt
    White, C. Michael
    FORMULARY, 2007, 42 (05) : 295 - +
  • [22] Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension
    O'Callaghan, Dermot S.
    Savale, Laurent
    Yaici, Azzedine
    Natali, Delphine
    Jais, Xavier
    Parent, Florence
    Montani, David
    Humbert, Marc
    Simonneau, Gerald
    Sitbon, Olivier
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (10) : 1585 - 1596
  • [23] Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension
    Langleben, David
    CLINICS IN CHEST MEDICINE, 2007, 28 (01) : 117 - +
  • [24] Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension: An Overview
    Raja, Shahzad G.
    CARDIOVASCULAR THERAPEUTICS, 2010, 28 (05) : e65 - e71
  • [25] Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis (vol 59, pg 8168, 2016)
    Aubert, John-David
    Juillerat-Jeanneret, Lucienne
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (04) : 1617 - 1617
  • [26] Treatment of pulmonary arterial hypertension by endothelin receptor antagonists in 2008
    Cacoub, P.
    Amoura, Z.
    Langleben, D.
    REVUE DE MEDECINE INTERNE, 2008, 29 (04): : 283 - 289
  • [27] Role of Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension
    Abman, Steven H.
    ANNUAL REVIEW OF MEDICINE, 2009, 60 : 13 - 23
  • [28] Evolution of Patients with Pulmonary Arterial Hypertension Starting Macitentan After the Discontinuation of Other Endothelin-Receptor Antagonists: Results of a Retrospective Study
    Cadenas-Menendez, Sergio
    Alvarez Vega, Pablo
    Oterino Manzanas, Armando
    Alonso Lecue, Pilar
    Roig Figueroa, Vicente
    Bedate Diaz, Pedro
    Ortiz de Saracho, Juan
    Cifrian Martinez, Jose Manuel
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (05) : 481 - 487
  • [29] Endothelin Receptor Antagonists for Pulmonary Arterial HypertensionRationale and Place in Therapy
    Laura C. Price
    Luke S. G. E. Howard
    American Journal of Cardiovascular Drugs, 2008, 8 : 171 - 185
  • [30] Evolution of Patients with Pulmonary Arterial Hypertension Starting Macitentan After the Discontinuation of Other Endothelin-Receptor Antagonists: Results of a Retrospective Study
    Sergio Cadenas-Menéndez
    Pablo Álvarez Vega
    Armando Oterino Manzanas
    Pilar Alonso Lecue
    Vicente Roig Figueroa
    Pedro Bedate Díaz
    Juan Ortiz de Saracho
    José Manuel Cifrián Martínez
    American Journal of Cardiovascular Drugs, 2020, 20 : 481 - 487
12345